CiToxLAB Names Barrow to Director Post

Paul C. Barrow has been named director of scientific projects and client consulting at CiToxLAB. With this appointment, CiToxLAB expects to further increase its business in reprotoxicology and juvenile studies. Mr. Barrow and François Spezia, recently recruited from Chanel, Pfizer and HMR, will be working jointly to further develop those capabilities, in conjunction with Scantox, the Danish site of the newly formed group, which has internationally recognized competencies in mini-pig studies.

Mr. Barrow has more than 30 years’ experience in preclinical safety testing, gained through working for the pharmaceutical industry and CROs in France, the UK and Italy. He spent the previous 10 years as the director of toxicology for Ricerca, where he collaborated with more than 100 clients from the pharmaceutical, biotech, chemical and food industries to devise and execute non-clinical regulatory submission packages and to address pre- and post-marketing safety issues.

Mr. Barrow is a member of the Society of Toxicology (SOT), the Teratology Society, the European Teratology Society, and Eurotox and is a European Registered Toxicologist. He sits on the editorial board of the journal Reproductive Toxicology. He has published dozens of peer-reviewed papers in the field of toxicology, two textbooks and several book chapters. He has participated in test guideline working groups for the OECD and in a joint scientific consultative group for the FDA/SOT. Mr. Barrow frequently presents his work at international scientific meetings and he occasionally lectures in toxicology at schools of medicine, pharmacy and veterinary science in Guildford, Lyon, Paris, and Toulouse.

Sophie Baratte, managing director of CiToxLAB France, said, “I am delighted that we are adding a colleague of this standard to our organization. Paul will bring further expertise and credibility to the CIT brand that has been established over the last 40 years.”